Rfp Financial Group LLC Novo Nordisk A S Transaction History

Rfp Financial Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$122.71 - $146.91 $6,012 - $7,198	-49 Reduced 6.43%	713 $101,000
Q1 2024 May 09, 2024	BUY	$102.11 - $135.92 $32,879 - $43,766	322 Added 73.18%	762 $97,000
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $20,006 - $43,898	220 Added 100.0%	440 $40,000
Q4 2022 Jan 24, 2023	BUY	$102.55 - $135.33 $22,561 - $29,772	220 New	220 $29.8 Million

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $252B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.